Latip, Abdul Amin A.
HRN: 24-17-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/27/2023
12/03/2023
IV
95mg
Q24
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes